The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Monoclonal Antibody Treatment-Global Market Insights and Sales Trends 2025
Synopsis
Monoclonal antibody treatment is a type of targeted therapy that uses specific antibodies to identify and attack cancer cells or other diseased cells in the body.
The global Monoclonal Antibody Treatment market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Monoclonal Antibody Treatment in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Monoclonal Antibody Treatment market. Cancer, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Autoimmune Diseases segment is estimated at % CAGR for the next seven-year period.
The market for monoclonal antibody treatment is driven by the increasing demand for personalized and targeted cancer therapies and the growing prevalence of various cancers and autoimmune diseases. The market's growth is also influenced by ongoing research and development in monoclonal antibodies, leading to the discovery of new therapeutic targets and treatment options.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Monoclonal Antibody Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Monoclonal Antibody Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Monoclonal Antibody Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Monoclonal Antibody Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Monoclonal Antibody Treatment covered in this report include Pfizer, Bayer, Sanofi, Merck, GlaxoSmithKline, Roche, Novartis, AbbVie and Shanghai Junshi Biosciences Co.,Ltd, etc.
The global Monoclonal Antibody Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Bayer
Sanofi
Merck
GlaxoSmithKline
Roche
Novartis
AbbVie
Shanghai Junshi Biosciences Co.,Ltd
Innovent Biologics
Jiangsu Hengrui Medicine Co.,Ltd.
BeiGene, Ltd.
Grand Pharmaceutical (China) Co., Ltd
Henlius
Global Monoclonal Antibody Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Monoclonal Antibody Treatment market, Segment by Type:
Cancer
Autoimmune Diseases
Exogenous Infection
Hematological Diseases
Global Monoclonal Antibody Treatment market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Monoclonal Antibody Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Monoclonal antibody treatment is a type of targeted therapy that uses specific antibodies to identify and attack cancer cells or other diseased cells in the body.
The global Monoclonal Antibody Treatment market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Monoclonal Antibody Treatment in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Monoclonal Antibody Treatment market. Cancer, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Autoimmune Diseases segment is estimated at % CAGR for the next seven-year period.
The market for monoclonal antibody treatment is driven by the increasing demand for personalized and targeted cancer therapies and the growing prevalence of various cancers and autoimmune diseases. The market's growth is also influenced by ongoing research and development in monoclonal antibodies, leading to the discovery of new therapeutic targets and treatment options.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Monoclonal Antibody Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Monoclonal Antibody Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Monoclonal Antibody Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Monoclonal Antibody Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Monoclonal Antibody Treatment covered in this report include Pfizer, Bayer, Sanofi, Merck, GlaxoSmithKline, Roche, Novartis, AbbVie and Shanghai Junshi Biosciences Co.,Ltd, etc.
The global Monoclonal Antibody Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Bayer
Sanofi
Merck
GlaxoSmithKline
Roche
Novartis
AbbVie
Shanghai Junshi Biosciences Co.,Ltd
Innovent Biologics
Jiangsu Hengrui Medicine Co.,Ltd.
BeiGene, Ltd.
Grand Pharmaceutical (China) Co., Ltd
Henlius
Global Monoclonal Antibody Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Monoclonal Antibody Treatment market, Segment by Type:
Cancer
Autoimmune Diseases
Exogenous Infection
Hematological Diseases
Global Monoclonal Antibody Treatment market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Monoclonal Antibody Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Monoclonal Antibody Treatment
1.1 Monoclonal Antibody Treatment Market Overview
1.1.1 Monoclonal Antibody Treatment Product Scope
1.1.2 Monoclonal Antibody Treatment Market Status and Outlook
1.2 Global Monoclonal Antibody Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Monoclonal Antibody Treatment Market Size by Region (2018-2029)
1.4 Global Monoclonal Antibody Treatment Historic Market Size by Region (2018-2023)
1.5 Global Monoclonal Antibody Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Monoclonal Antibody Treatment Market Size (2018-2029)
1.6.1 North America Monoclonal Antibody Treatment Market Size (2018-2029)
1.6.2 Europe Monoclonal Antibody Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Monoclonal Antibody Treatment Market Size (2018-2029)
1.6.4 Latin America Monoclonal Antibody Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Monoclonal Antibody Treatment Market Size (2018-2029)
2 Monoclonal Antibody Treatment Market by Type
2.1 Introduction
2.1.1 Cancer
2.1.2 Autoimmune Diseases
2.1.3 Exogenous Infection
2.1.4 Hematological Diseases
2.2 Global Monoclonal Antibody Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Monoclonal Antibody Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Monoclonal Antibody Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Monoclonal Antibody Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Monoclonal Antibody Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Monoclonal Antibody Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Monoclonal Antibody Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Monoclonal Antibody Treatment Revenue Breakdown by Type (2018-2029)
3 Monoclonal Antibody Treatment Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Others
3.2 Global Monoclonal Antibody Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Monoclonal Antibody Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Monoclonal Antibody Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Monoclonal Antibody Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Monoclonal Antibody Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Monoclonal Antibody Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Monoclonal Antibody Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Monoclonal Antibody Treatment Revenue Breakdown by Application (2018-2029)
4 Monoclonal Antibody Treatment Competition Analysis by Players
4.1 Global Monoclonal Antibody Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Monoclonal Antibody Treatment as of 2022)
4.3 Date of Key Players Enter into Monoclonal Antibody Treatment Market
4.4 Global Top Players Monoclonal Antibody Treatment Headquarters and Area Served
4.5 Key Players Monoclonal Antibody Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Monoclonal Antibody Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Pfizer
5.1.1 Pfizer Profile
5.1.2 Pfizer Main Business
5.1.3 Pfizer Monoclonal Antibody Treatment Products, Services and Solutions
5.1.4 Pfizer Monoclonal Antibody Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 Pfizer Recent Developments
5.2 Bayer
5.2.1 Bayer Profile
5.2.2 Bayer Main Business
5.2.3 Bayer Monoclonal Antibody Treatment Products, Services and Solutions
5.2.4 Bayer Monoclonal Antibody Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 Bayer Recent Developments
5.3 Sanofi
5.3.1 Sanofi Profile
5.3.2 Sanofi Main Business
5.3.3 Sanofi Monoclonal Antibody Treatment Products, Services and Solutions
5.3.4 Sanofi Monoclonal Antibody Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 Merck Recent Developments
5.4 Merck
5.4.1 Merck Profile
5.4.2 Merck Main Business
5.4.3 Merck Monoclonal Antibody Treatment Products, Services and Solutions
5.4.4 Merck Monoclonal Antibody Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 Merck Recent Developments
5.5 GlaxoSmithKline
5.5.1 GlaxoSmithKline Profile
5.5.2 GlaxoSmithKline Main Business
5.5.3 GlaxoSmithKline Monoclonal Antibody Treatment Products, Services and Solutions
5.5.4 GlaxoSmithKline Monoclonal Antibody Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 GlaxoSmithKline Recent Developments
5.6 Roche
5.6.1 Roche Profile
5.6.2 Roche Main Business
5.6.3 Roche Monoclonal Antibody Treatment Products, Services and Solutions
5.6.4 Roche Monoclonal Antibody Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 Roche Recent Developments
5.7 Novartis
5.7.1 Novartis Profile
5.7.2 Novartis Main Business
5.7.3 Novartis Monoclonal Antibody Treatment Products, Services and Solutions
5.7.4 Novartis Monoclonal Antibody Treatment Revenue (US$ Million) & (2018-2023)
5.7.5 Novartis Recent Developments
5.8 AbbVie
5.8.1 AbbVie Profile
5.8.2 AbbVie Main Business
5.8.3 AbbVie Monoclonal Antibody Treatment Products, Services and Solutions
5.8.4 AbbVie Monoclonal Antibody Treatment Revenue (US$ Million) & (2018-2023)
5.8.5 AbbVie Recent Developments
5.9 Shanghai Junshi Biosciences Co.,Ltd
5.9.1 Shanghai Junshi Biosciences Co.,Ltd Profile
5.9.2 Shanghai Junshi Biosciences Co.,Ltd Main Business
5.9.3 Shanghai Junshi Biosciences Co.,Ltd Monoclonal Antibody Treatment Products, Services and Solutions
5.9.4 Shanghai Junshi Biosciences Co.,Ltd Monoclonal Antibody Treatment Revenue (US$ Million) & (2018-2023)
5.9.5 Shanghai Junshi Biosciences Co.,Ltd Recent Developments
5.10 Innovent Biologics
5.10.1 Innovent Biologics Profile
5.10.2 Innovent Biologics Main Business
5.10.3 Innovent Biologics Monoclonal Antibody Treatment Products, Services and Solutions
5.10.4 Innovent Biologics Monoclonal Antibody Treatment Revenue (US$ Million) & (2018-2023)
5.10.5 Innovent Biologics Recent Developments
5.11 Jiangsu Hengrui Medicine Co.,Ltd.
5.11.1 Jiangsu Hengrui Medicine Co.,Ltd. Profile
5.11.2 Jiangsu Hengrui Medicine Co.,Ltd. Main Business
5.11.3 Jiangsu Hengrui Medicine Co.,Ltd. Monoclonal Antibody Treatment Products, Services and Solutions
5.11.4 Jiangsu Hengrui Medicine Co.,Ltd. Monoclonal Antibody Treatment Revenue (US$ Million) & (2018-2023)
5.11.5 Jiangsu Hengrui Medicine Co.,Ltd. Recent Developments
5.12 BeiGene, Ltd.
5.12.1 BeiGene, Ltd. Profile
5.12.2 BeiGene, Ltd. Main Business
5.12.3 BeiGene, Ltd. Monoclonal Antibody Treatment Products, Services and Solutions
5.12.4 BeiGene, Ltd. Monoclonal Antibody Treatment Revenue (US$ Million) & (2018-2023)
5.12.5 BeiGene, Ltd. Recent Developments
5.13 Grand Pharmaceutical (China) Co., Ltd
5.13.1 Grand Pharmaceutical (China) Co., Ltd Profile
5.13.2 Grand Pharmaceutical (China) Co., Ltd Main Business
5.13.3 Grand Pharmaceutical (China) Co., Ltd Monoclonal Antibody Treatment Products, Services and Solutions
5.13.4 Grand Pharmaceutical (China) Co., Ltd Monoclonal Antibody Treatment Revenue (US$ Million) & (2018-2023)
5.13.5 Grand Pharmaceutical (China) Co., Ltd Recent Developments
5.14 Henlius
5.14.1 Henlius Profile
5.14.2 Henlius Main Business
5.14.3 Henlius Monoclonal Antibody Treatment Products, Services and Solutions
5.14.4 Henlius Monoclonal Antibody Treatment Revenue (US$ Million) & (2018-2023)
5.14.5 Henlius Recent Developments
6 North America
6.1 North America Monoclonal Antibody Treatment Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Monoclonal Antibody Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Monoclonal Antibody Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Monoclonal Antibody Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Monoclonal Antibody Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Monoclonal Antibody Treatment Market Dynamics
11.1 Monoclonal Antibody Treatment Industry Trends
11.2 Monoclonal Antibody Treatment Market Drivers
11.3 Monoclonal Antibody Treatment Market Challenges
11.4 Monoclonal Antibody Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
